Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus

A.H. van Lierop, N.A.T. Hamdy, R.W. van der Meer, J.T. Jonker, H.J. Lamb, L.J. Rijzewijk, M. Diamant, J.A. Romijn, J.W.A. Smit, S.E. Papapoulos

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)711-716
JournalEuropean Journal of Endocrinology
Volume166
Issue number4
DOIs
Publication statusPublished - 2012

Cite this

van Lierop, A. H., Hamdy, N. A. T., van der Meer, R. W., Jonker, J. T., Lamb, H. J., Rijzewijk, L. J., ... Papapoulos, S. E. (2012). Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus. European Journal of Endocrinology, 166(4), 711-716. https://doi.org/10.1530/EJE-11-1061